Application Information

This drug has been submitted to the FDA under the reference 208684/001.

Names and composition

"EMFLAZA" is the commercial name of a drug composed of DEFLAZACORT.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
208684/001 EMFLAZA DEFLAZACORT TABLET/ORAL 6MG
208684/002 EMFLAZA DEFLAZACORT TABLET/ORAL 18MG
208684/003 EMFLAZA DEFLAZACORT TABLET/ORAL 30MG
208684/004 EMFLAZA DEFLAZACORT TABLET/ORAL 36MG
208685/001 EMFLAZA DEFLAZACORT SUSPENSION/ORAL 22.75MG per ML

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
208684/001 EMFLAZA DEFLAZACORT TABLET/ORAL 6MG
208684/002 EMFLAZA DEFLAZACORT TABLET/ORAL 18MG
208684/003 EMFLAZA DEFLAZACORT TABLET/ORAL 30MG
208684/004 EMFLAZA DEFLAZACORT TABLET/ORAL 36MG
208685/001 EMFLAZA DEFLAZACORT SUSPENSION/ORAL 22.75MG per ML

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved